Choosing an assisted reproduction route for blocked tubes and a low sperm count
A 34-year-old woman and her 38-year-old husband attend a fertility clinic after 6 years of trying to conceive. Her cycles are regular; day-3 FSH is 9 IU/L and AMH 1.1 ng/mL. A hysterosalpingogram shows bilateral blocked tubes, with a dilated, fluid-filled left tube (hydrosalpinx). The uterus is normal on ultrasound. The husband's semen analysis gives volume 3.0 mL, concentration 12 million/mL, 30% motile and 3% normal morphology (WHO lower reference limits: 1.4 mL, 16 million/mL, 42% motile, 4% normal forms). He has a grade 1 varicocele. The couple's savings would cover one fresh IVF cycle or three IUI cycles, and they ask the clinic to 'do the strongest treatment first so we do not waste time'.
1. Rule in or rule out intrauterine insemination for this couple and justify the decision from the tubal and semen findings. Is intracytoplasmic sperm injection indicated by the numbers alone?
Read the worked answer
Intrauterine insemination requires at least one patent tube, because fertilisation must still happen inside the tube; the insemination only improves sperm delivery. With bilateral tubal block and a hydrosalpinx, sperm and oocyte cannot meet, so three IUI cycles would give close to zero chance of conception. The couple's savings are most likely to be wasted on IUI, not on IVF.
IVF is therefore the indicated route, and it is not 'the strongest' but the only one that bypasses the tubes. The semen values are just below WHO lower limits - total motile sperm here is about 11 million, which is reduced but compatible with conventional insemination in vitro. ICSI is not indicated by these numbers alone: it is reserved for severe oligozoospermia, poor or absent motility after preparation, surgically retrieved sperm, previous total or near-total fertilisation failure, or preimplantation genetic testing for monogenic disease. Offering ICSI to all couples does not raise live-birth rates in non-severe male factor, and it adds cost and small procedural risks. The reasonable plan is conventional IVF with a check on fertilisation and rescue ICSI if fewer than about 30% of oocytes fertilise.
2. Explain why the hydrosalpinx must be managed before embryo transfer, and why the AMH value changes how the couple should be counselled about delay.
Read the worked answer
A hydrosalpinx is not a passive blockage. The fluid is embryotoxic and inflammatory, and it can reflux into the uterine cavity, physically washing out or damaging embryos; it also alters endometrial receptivity. Cycles in women with an untreated hydrosalpinx show lower implantation and live-birth rates and higher miscarriage rates, so the tube should be removed (salpingectomy) or disconnected proximally before transfer. The benefit is large enough that it is worth one surgical step before an expensive IVF cycle.
AMH of 1.1 ng/mL at age 34 indicates a diminished ovarian reserve: fewer oocytes will be retrieved per cycle, so the margin for failed cycles is thin. Time is not neutral here - both reserve and oocyte quality decline with age - so the counselling should be that waiting for repeated low-yield attempts is the real risk. The plan should be one well-planned stimulated cycle with an antagonist protocol to reduce ovarian hyperstimulation risk, and consideration of freezing all suitable embryos so that a failed fresh transfer does not require another stimulation.
3. How many embryos should be transferred, and how would you answer the couple's request for 'the strongest treatment first'? Include the reasoning about multiple pregnancy.
Read the worked answer
At 34 with a good-prognosis cycle, elective single embryo transfer at blastocyst stage is the correct default. The reasoning is that the main added risk of transferring two is not a higher chance of a live birth per transfer but a much higher chance of twins, and twins carry increased preterm birth, low birth weight, pre-eclampsia, gestational diabetes and perinatal mortality for mother and babies. Transferring one embryo and vitrifying the rest gives a cumulative live-birth rate over successive frozen transfers that is close to that of double transfer, while avoiding most twin pregnancies. Double transfer is reserved for poor-quality embryos, repeated implantation failure or a woman with a poor prognosis in whom the chance of a single embryo implanting is low.
On 'strongest first': strength is not a dial. The couple's chance depends on maternal age, oocyte yield, embryo quality and the treated hydrosalpinx, not on doing every technique at once. The honest answer is that the sequence with the best chance is tube surgery, one stimulated cycle, single blastocyst transfer and use of frozen embryos from the same cohort - with realistic clinic-specific success figures quoted, not guarantees.